Informed Consent for Prostate Screening with Prostate Specific Antigen in African American, Hispanic, and Caucasians
Annual rept. 1 Feb 2000-31 Jan 2001
TEXAS UNIV HEALTH SCIENCE CENTER AT HOUSTON
Pagination or Media Count:
PROSTATE CANCER SCREENING WITH PROSTATE SPECIFIC ANTIGEN PSA is controversial because it is not clear whether it reduces the mortality and morbidity from prostate cancer. Several professional organizations recommend informing men about the risks and benefits of screening. The purpose of this award was to develop educational brochures about prostate cancer screening with PSA for African Americans, Hispanics, and under-served Caucasians, and thereby promote informed decision making about screening. We have completed focus group meetings for the African Americans and Caucasians and have developed a prototype brochure for each group that we are now refining. African Americans felt strongly that a brochure should include the advantages and disadvantages of screening with the digital rectal exam, as well as PSA, because of its perceived embarrassment. They also wanted graphics reflecting their African roots. We have convened one Hispanic focus group and are recruiting another for Hispanic brochure development. In the training component of this award, Dr. Chan has completed course work in biostatistics at the University of Texas School of public Health. Results of the work completed so far have been accepted for presentation at the national meeting of the Society of General Internal Medicine.
- Anatomy and Physiology
- Medicine and Medical Research